Skip to main content
Bio-Techne10-K: Compliance burden

Facing stricter EU In Vitro Diagnostic Regulation (IVDR), requiring system and process changes

What happened

New EU IVDR rules are imposing significant compliance costs, potentially requiring material modifications to quality management systems, additional resources, and updates to technical files.

Source

SEC EDGARAug 24, 2026

Annual report (Form 10-K)

Bio-Techne 10-K

Filing excerpt

Additionally, the EU has adopted the In Vitro Diagnostic Regulation (the “EU IVDR”), which imposes stricter requirements for the marketing and sale of in vitro diagnostic medical devices...

sec.gov/Archives/edgar/data/842023/000110465926100322/tech-20260630x1...Read the full source

Other signals in this filing (10)

Extracted by Autobound

From the Signal API record
Signal
10-K: Compliance burden

What this signalsFilings often name leadership changes, deals and spending plans.

Filed
Aug 24, 2026

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
842023
Accession number
0001104659-26-100322
Timeframe
Current year
Filing year
2026
Why it matters
GRC tools needed
Signal category
Risk

Topics and mentions

Regions named

  • Europe

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Aug 25, 2026
signal_type
sec-10k
signal_subtype
complianceBurden

Use this data

Get every 10-K signal for Bio-Techne and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bio-Techne this week?”

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/0f291a48-e9ce-40b0-852f-09039c80402f returns this record as JSON. POST /v1/companies/enrich returns every signal for bio-techne.com.

{
  "signal_id": "0f291a48-e9ce-40b0-852f-09039c80402f",
  "signal_type": "sec-10k",
  "signal_subtype": "complianceBurden",
  "detected_at": "2026-08-25T07:04:13.44+00:00",
  "company": {
    "name": "Bio-Techne",
    "domain": "bio-techne.com"
  },
  "data": {
    "detail": "New EU IVDR rules are imposing significant compliance costs, potentially requiring material modifications to quality management systems, additional resources, and updates to technical files. This creates an immediate need for compliance software, regulatory consulting, and data management solutions.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Facing stricter EU In Vitro Diagnostic Regulation (IVDR), requiring system and process changes",
    "excerpts": "Additionally, the EU has adopted the In Vitro Diagnostic Regulation (the “EU IVDR”), which imposes stricter requirements for the marketing and sale of in vitro diagnostic medical devices...",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/842023/000110465926100322/tech-20260630x10k.htm",
    "filing_date": "2026-08-24",
    "filing_year": 2026,
    "sales_relevance": "GRC tools needed",
    "signal_category": "risk",
    "regions_mentioned": [
      "Europe"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.